Supplementary Figure S2 from Repurposing the DNA Labeling Agent EdU for Therapy against Heterogeneous Patient Glioblastoma

<p>Figure S2: Features of glioblastoma models used to assess therapeutic potential of EdU. The features in red are less than desirable, blue are moderately desirable, and green are ideal. As such, the compounds were tested on multiple cell culture platforms to supplement the weaknesses of indi...

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoir: Humeyra Kaanoglu (21903844) (author)
Rannpháirtithe: Adebimpe Adefolaju (21903847) (author), Casey Fraley (21903850) (author), Mariah Shobande (21903853) (author), Rajaneekar Dasari (21903856) (author), Breanna Mann (21903859) (author), Noah Bell (21903862) (author), Stephen T. Keir (18724623) (author), Dominique Higgins (21903865) (author), David E. Kram (15110825) (author), Shawn D. Hingtgen (21903868) (author), Aziz Sancar (21903871) (author), Andrew B. Satterlee (21903874) (author)
Foilsithe / Cruthaithe: 2025
Ábhair:
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
Cur síos
Achoimre:<p>Figure S2: Features of glioblastoma models used to assess therapeutic potential of EdU. The features in red are less than desirable, blue are moderately desirable, and green are ideal. As such, the compounds were tested on multiple cell culture platforms to supplement the weaknesses of individual platforms.</p>